Article

Autoimmune Inflammatory Reactions Triggered by the COVID-19 Genetic Vaccines in Terminally Differentiated Tissues

2023-03-08

Abstract excerpt

As a result of the spread of SARS-CoV-2, a global pandemic was declared. Indiscriminate COVID-19 vaccination has been extended to include age groups and naturally immune people with minimal danger of suffering serious complications due to COVID-19. Solid immuno-histopathological evidence demonstrates that the COVID-19 genetic vaccines can display an off-target distribution in tissues that are terminally differenti...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: dcbf5719-51c9-5f24-ae85-377d8ced193c
DOI: 10.20944/preprints202303.0140.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Autoimmune Inflammatory Reactions Triggered by the COVID-19 Genetic Vaccines in Terminally Differentiated TissuesDOI 10.20944/preprints202303.0140.v1Read

Expanded Spectrum and Increased Incidence of Adverse Events Linked to COVID-19 Genetic Vaccines: New Concepts on Prophylactic Immuno-Gene Therapy, Iatrogenic Orphan Disease and Platform-Inherent ChallengesSemantic proximity Read

COVID-19 mRNA Vaccines: From Inflammation to HyperinflammationSemantic proximity Read

Autoimmunity and Antibody Dependent COVID-19 Enhancement of SARS CoV-2 Vaccination: A Global Human Right to Know then Decide.Semantic proximity Read

The Impact of COVID-19 Vaccination on Autoimmune Disorders: A Descriptive AnalysisSemantic proximity Read

SARS-CoV-2 mass vaccination: Urgent questions on vaccine safety that demand answers from international health agencies, regulatory authorities, governments and vaccine developersSemantic proximity Read

The Unique Features and Collateral Immune Effects of mRNA-Based COVID-19 Vaccines: Potential Plausible Causes of Adverse Events and ComplicationsSemantic proximity Read

Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendationsSemantic proximity Read

Recent developments in the immunopathology of COVID-19Semantic proximity Read

A drug candidate for treating adverse reactions caused by pathogenic antibodies inducible by COVID-19 virus and vaccinesSemantic proximity Read

Cardiac Inflammation after COVID-19 mRNA Vaccines: A Global Pharmacovigilance AnalysisSemantic proximity Read

Immune targeted therapies for COVID-19 Infection: A Promising OutlookSemantic proximity Read

Nature Of, Immune Reaction to and Side Effects of COVID-19 Vaccines: Synthesis of Information Including Exclusions from Ten Phase II Trials for Planning Vaccination ProgrammesSemantic proximity Read